CRIS Current Research Information System

ZOLI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.899
AS - Asia 12.706
EU - Europa 11.729
SA - Sud America 794
AF - Africa 752
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 8
Totale 42.921
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.678
VN - Vietnam 4.176
IT - Italia 3.274
SG - Singapore 3.256
CN - Cina 2.678
GB - Regno Unito 2.197
DE - Germania 1.455
SE - Svezia 1.180
HK - Hong Kong 819
FR - Francia 646
IN - India 645
BR - Brasile 565
RU - Federazione Russa 528
NL - Olanda 481
UA - Ucraina 395
IE - Irlanda 392
CH - Svizzera 288
FI - Finlandia 214
ZA - Sudafrica 212
TG - Togo 211
JP - Giappone 203
EE - Estonia 175
BD - Bangladesh 151
KR - Corea 144
BG - Bulgaria 141
CI - Costa d'Avorio 133
CA - Canada 129
JO - Giordania 106
AR - Argentina 86
PH - Filippine 81
SC - Seychelles 67
AT - Austria 65
TH - Thailandia 65
BE - Belgio 56
ES - Italia 55
ID - Indonesia 53
PL - Polonia 51
MX - Messico 45
IQ - Iraq 41
TR - Turchia 40
EC - Ecuador 36
UZ - Uzbekistan 32
SA - Arabia Saudita 31
CL - Cile 29
TW - Taiwan 28
CD - Congo 27
IR - Iran 27
PK - Pakistan 27
AU - Australia 26
CO - Colombia 26
GR - Grecia 24
NG - Nigeria 24
MY - Malesia 23
HR - Croazia 21
PE - Perù 17
MA - Marocco 15
AE - Emirati Arabi Uniti 14
EG - Egitto 14
LB - Libano 13
RO - Romania 13
CZ - Repubblica Ceca 12
JM - Giamaica 12
LT - Lituania 12
PY - Paraguay 12
IL - Israele 11
VE - Venezuela 11
KE - Kenya 10
TN - Tunisia 10
ET - Etiopia 9
DK - Danimarca 8
DZ - Algeria 7
HU - Ungheria 7
NP - Nepal 7
NZ - Nuova Zelanda 7
RS - Serbia 6
UY - Uruguay 6
AL - Albania 5
AZ - Azerbaigian 5
BO - Bolivia 5
CR - Costa Rica 5
MK - Macedonia 5
OM - Oman 5
PT - Portogallo 5
XK - ???statistics.table.value.countryCode.XK??? 5
KZ - Kazakistan 4
NO - Norvegia 4
SN - Senegal 4
AM - Armenia 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
KH - Cambogia 3
LU - Lussemburgo 3
LV - Lettonia 3
NI - Nicaragua 3
AG - Antigua e Barbuda 2
CY - Cipro 2
DM - Dominica 2
EU - Europa 2
GH - Ghana 2
HN - Honduras 2
Totale 42.876
Salva come PNG Salva come JPEG
Città #
Singapore 2.201
Southend 1.880
Ashburn 1.761
Fairfield 1.730
Chandler 1.386
Ho Chi Minh City 813
Woodbridge 767
Hong Kong 759
Dong Ket 742
Santa Clara 732
Seattle 718
Hanoi 689
San Jose 688
Wilmington 665
Houston 652
Cambridge 600
Princeton 487
Ann Arbor 452
Dublin 390
Bologna 388
Beijing 376
Boardman 324
Frankfurt am Main 286
Bern 261
Hefei 256
Los Angeles 245
Lauterbourg 242
Lomé 211
Nanjing 209
Milan 208
Jacksonville 206
Westminster 199
Padova 187
Rome 181
Tokyo 181
Florence 178
New York 175
Council Bluffs 173
Helsinki 168
Da Nang 153
Berlin 147
Dallas 143
Sofia 139
Abidjan 133
Buffalo 112
Saint Petersburg 110
Amman 106
Haiphong 104
São Paulo 102
Bremen 101
Turin 100
Jinan 99
Munich 95
Seoul 95
San Diego 88
Shenyang 84
Redondo Beach 83
Brescia 79
Nanchang 79
Changsha 78
Redmond 76
Cesena 71
Guangzhou 63
Hebei 61
Naples 57
Orem 57
Shanghai 57
Brussels 55
Des Moines 55
Tianjin 52
Chicago 51
Amsterdam 50
Falls Church 50
Medford 49
Phoenix 49
Hangzhou 48
London 46
Jiaxing 45
San Francisco 45
Bengaluru 43
Dearborn 43
Atlanta 42
Biên Hòa 41
Pune 41
Hải Dương 38
Mülheim 38
Redwood City 37
Toronto 37
Montreal 35
Denver 33
Paris 33
Can Tho 32
Palermo 32
Thái Nguyên 32
Ningbo 31
Zhengzhou 31
Falkenstein 30
Warsaw 30
Yubileyny 30
Haikou 29
Totale 26.771
Salva come PNG Salva come JPEG
Nome #
DIABETE MELLITO TIPO 2 ED EVENTI ARITMICI NEL PAZIENTE ANZIANO. OSSERVAZIONI MEDIANTE MONITORAGGIO ECG HOLTER 1.663
Bioavailable testosterone linearly declines over a wide age spectrum in men and women from the Baltimore longitudinal study of aging. 946
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 482
Prognostic value of non-alcoholic fatty liver disease in the elderly patients 409
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 359
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 288
Prognostic role of nutritional status in elderly patients hospitalized for COVID-19: a monocentric study 279
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. 268
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 267
Appropriateness of Proton Pump Inhibitor (PPI) prescription in patients admitted to hospital: Attitudes of general practitioners and hospital physicians in Italy 262
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 262
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 257
Accuracy of Lung Ultrasound in Patients with Acute Dyspnea: The Influence of Age, Multimorbidity and Cognitive and Motor Impairment 256
T-31 Nonalcoholic fatty liver disease and aging. Clinical course and cardiovascular risk 255
“Delirium Day”: a nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 254
Chronic endurance exercise training prevents aging-related cognitive decline in healthy older adults: a randomized controlled trial. 252
Adipocyte-fatty acid binding protein and non-alcoholic fatty liver disease in the elderly 250
Association between accelerated multimorbidity and age-related cognitive decline in older Baltimore longitudinal study of aging participants without dementia. 250
Risk of Exclusion From Stroke Rehabilitation in the Oldest Old 250
Clinical Features Associated with Delirium Motor Subtypes in Older Inpatients: Results of a Multicenter Study 248
Effects of weight loss and risk factor treatment in subjects with elevated serum C3, an inflammatory predictor of myocardial infarction. 245
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 244
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 244
Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis 242
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 242
Pattern of macrovascular invasion in hepatocellular carcinoma 242
A nomogram-based prognostic model for advanced hepatocellular carcinoma patients treated with sorafenib: A multicenter study 242
Aging and the burden of multimorbidity: Associations with inflammatory and anabolic hormonal biomarkers 235
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma 235
MARK-AGE population: From the human model to new insights 233
Risk of hospitalization from drug-drug interactions in the Elderly: real-world evidence in a large administrative database 227
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study 226
BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group. 223
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 219
Adverse effects of proton pump inhibitors. 219
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma. 219
Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinoma 218
Postprandial splanchnic haemodynamic changes in patients with liver cirrhosis and patent paraumbilical vein 216
Age dependency of regional impedance indices regardless of clinical stage in patients with cirrhosis of the liver 216
Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study Group 213
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study 212
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatments and outcome. 212
Psychological status and depression in patients with liver cirrhosis 210
N-terminal pro B-type natriuretic peptide (NT-proBNP): a possible surrogate of biological age in the elderly people 210
T-30 Cognitive profiles in patients with cirrhosis and long-term liver transplant recipients 210
The changing scenario of hepatocellular carcinoma in Italy: an update 209
Long-term beta-blockade shortens Qt interval prolongation in patients with liver cirrhosis 209
The Senile Lung as a Possible Source of Pitfalls on Chest Ultrasonography and Computed Tomography 209
Predictors of cognitive impairment assessed by Mini Mental State Examination in community-dwelling older adults: relevance of the step test 209
Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20 year multicentre experience. 208
Application of the Intermediate-Stage Subclassification to Patients with Untreated Hepatocellular Carcinoma 208
Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA. database 208
Age-specific rate of undiagnosed diabetes and prediabetes in acute stroke 207
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma 205
Aging and Multimorbidity: New Tasks, Priorities, and Frontiers for Integrated Gerontological and Clinical Research 204
Inverse Association Between Neck Pain and All-Cause Mortality in Community-Dwelling Older Adults 203
T-33 Liver steatosis in old subjects could be a predictor of possible cardiac abnormalities 201
Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients 200
Metabolic disorders across hepatocellular carcinoma in Italy 200
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 200
Plasma homocysteine and inflammation in elderly patients with cardiovascular disease and dementia. 199
A Case of Acute Liver Failure during Ritonavir-Boosted Paritaprevir, Ombitasvir and Dasabuvir Therapy in a Patient with HCV Genotype 1b Cirrhosis 195
The association of proBNPage with manifestations of age-related cardiovascular, physical, and psychological impairment in community-dwelling older adults 194
Octreotide in the outpatient therapy of cirrhotic chylous ascites: a case report. 191
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice 190
Surveillance for hepatocellular carcinoma in elderly italian patients with cirrhosis. Effects on cancer staging and patients survival. 190
Clinical Role of Lung Ultrasound for the Diagnosis and Prognosis of Coronavirus Disease Pneumonia in Elderly Patients: A Pivotal Study 190
Insulin Resistance Is Associated With Reduced Mitochondrial Oxidative Capacity Measured by 31P-Magnetic Resonance Spectroscopy in Participants Without Diabetes From the Baltimore Longitudinal Study of Aging 189
Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis. 188
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance. 188
Serum C3 is a stronger inflammatory marker of insulin resistance than C reactive protein, leukocyte count, and erythrocyte sedimentation rate. Comparison study in an elderly population. 186
Peliosis hepatis as an early histological finding in idiopathic portal hypertension: a case report. 186
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly. 185
Alfa-fetoprotein in hepatocellular carcinoma (HCC): diagnostic and prognostic role, clinical and biological predictors. Analysis of 1099 patients. 185
Primary prophylaxis with nadolol in cirrhotic patients: Doppler patterns of splanchnic hemodynamics in good and poor responders. 184
Serum dehydroepiandrosterone sulfate and adverse health outcomes in older men and women. 183
In portal hypertensive cirrhotic patients abdominal porto-systemic collaterals at ultrasound identify a group of patients at high risk of death 183
Determinants of mean platelet volume (MPV) in an elderly population: Relevance of body fat, blood glucose and ischaemic electrocardiographic changes. 182
Post COVID-19 irritable bowel syndrome 181
A comparative assessment of C3 complement, C-reactive protein, leukocyte count and erythrocyte sedimentation rate as inflammatory markers of insulin resistance in an elderly population 181
Prognostic value of a single HVPG measurement and Doppler-ultrasound evaluation in patients with cirrhosis and portal hypertension 180
Mortality after admission to stroke unit for intracerebral hemorrhage: Effect of age 80 and older and multimorbidity 180
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study. 180
Circulating ceramides are inversely associated with cardiorespiratory fitness in participants aged 54-96 years from the Baltiore Longitudinal Study of Aging. 180
Need for deprescribing in hospital elderly patients discharged with a limited life expectancy: The REPOSI study 180
Combination of the clock drawing test with the physical phenotype of frailty for the prediction of mortality and other adverse outcomes in older community dwellers without dementia 178
Physical Activity and Other Determinants of Survival in the Oldest Adults 178
Plasma amino acid concentrations in patients with Amnestic Mild Cognitive Impairment or Alzheimer Disease 177
Early body composition, but not body mass, is associated with future accelerated decline in muscle quality 177
"Physical Fitness and life extension." Lo studio Pianoro 176
Liver hemangioma and vascular liver diseases in patients with systemic lupus erythematosus. 176
Age as a possible Independent Prognostic Factor for Overall Survival and Recurrence-Free Survival after Transarterial Chemoembolization in Hepatocellular Carcinoma Patients 174
Loss of weight in obese older adults: A biomarker of impending expansion of multimorbidity? 173
Torsade de pointes” during amiodarone infusion in cirrhotic woman with the prolonged QT interval. 172
Hepatic decompensation is the major driver of death In HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma. 172
Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications 172
Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma 169
Albumin-induced hematocrit-lowering and B-type natriuretic peptide increase 169
EQ-5D as a predictor of mortality and hospitalization in elderly people. 169
Metabolic syndrome and all-cause mortality in older men and women. 169
Totale 23.742
Salva come PNG Salva come JPEG
Categoria #
all - tutte 115.391
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 115.391
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.337 0 0 0 0 0 0 0 0 0 0 0 1.337
2021/20224.701 385 141 279 289 421 258 140 287 216 289 1.233 763
2022/20235.725 572 916 289 736 282 405 198 311 881 149 541 445
2023/20241.682 104 241 100 157 179 343 79 83 93 107 93 103
2024/20256.002 265 863 501 444 1.058 335 399 200 132 477 257 1.071
2025/202613.919 998 908 1.013 889 1.438 840 1.898 395 2.738 1.057 562 1.183
Totale 43.580